Medtronic Appoints New Operating Unit Presidents

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – bringing in critical skills and capabilities and creating opportunities for internal talent.

“The future of medical technology requires strong leadership in data science, artificial intelligence, and robotics, all of which make these three Operating Unit President roles some of the most important and dynamic leadership opportunities in our industry,” said Geoff Martha, Medtronic chairman and chief executive officer. “These appointments not only strengthen our businesses and build our technology expertise; they also further establish Medtronic as a destination for world-class talent.”

Que Dallara joins as Executive Vice President and Operating Unit President, Diabetes
Que Dallara joins the Medtronic Executive Committee reporting to Chairman and CEO Geoff Martha on May 2, 2022. Dallara comes from Honeywell where she served as President and CEO of Honeywell Connected Enterprise, and earlier as SVP and chief commercial officer. She also held general manager and strategy roles at TE Connectivity Ltd. and Microsoft, after working at McKinsey in her early career.

Experienced in new product development and commercialization, Dallara has managed robust product portfolios, led end-to-end R&D innovation, and business development initiatives that strengthened organic and inorganic company growth. She will bring unique and meaningful perspective and experiences to the Diabetes business and Medtronic Executive Committee.

In this role, Dallara succeeds Sean Salmon, executive vice president and president, Cardiovascular Portfolio and Diabetes Operating Unit, who now turns to focus exclusively on leading the Cardiovascular Portfolio. Salmon will ensure continuity and support Dallara’s transition into the Diabetes business. He continues as a member of the Medtronic Executive and Capital Allocation Committees, helping to lead the company’s enterprise strategy.

Mike Marinaro named Operating Unit President, Surgical Robotics
Marinaro joins the Medical Surgical Portfolio leadership team reporting to Executive Vice President and President, Bob White. Marinaro is a seasoned leader with more than 20 years of experience and success at Medtronic. Previously, he led the Cardiac Rhythm Management Operating Unit with annualized revenue of more than $4 billion. Under Marinaro’s leadership, the business launched and scaled the Micra leadless pacemaker product line to more than $400 million annualized revenue.

Marinaro is known for his strong focus on innovation, commercialization, and scaling businesses and building inclusive work environments – ideal attributes to help continue Surgical Robotics’ growth trajectory.

Marinaro succeeds Megan Rosengarten, who is taking a planned six-month sabbatical to spend more time with her family with the full support of Medtronic. Rosengarten has successfully led the Surgical Robotics business for the past four years, steering the Hugo RAS System from early development to commercialization, and leading the acquisition of the Digital Surgery business.

Dr. Kweli Thompson named Operating Unit President, Cardiac Rhythm Management
Dr. Thompson joins the Cardiovascular Portfolio leadership team reporting to Salmon. Dr. Thompson is an accomplished medical technology leader with two decades of experience in business development, clinical research, product marketing, and general management. Dr. Thompson is known for accelerating performance, growth, and profitability. Previously, as vice president and general manager of the Cardiac Resynchronization and Defibrillation Solutions businesses, a part of Cardiac Rhythm Management, he led Defibrillation Solutions to the highest market share in three years and the highest Cardiac Resynchronization Therapy market share in more than a decade.

Other Executives In the News

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy